What is dose titration in peptide research?

Dose titration is the gradual escalation of dosage over specified intervals (typically 4-week steps). This allows the subject's receptors and gastrointestinal system to acclimate, reducing transient side effects.

Why do GLP-1 receptor agonists require a 4-week ramp phase?

Clinical trials for GLP-1 medications (like semaglutide and tirzepatide) showed that stepping up dosage every 4 weeks significantly minimizes nausea and GI intolerance compared to rapid dosing escalation.

What is dose titration in peptide research?

Dose titration is the gradual escalation of dosage over specified intervals (typically 4-week steps). This allows the subject's receptors and gastrointestinal system to acclimate, reducing transient side effects.

Why do GLP-1 receptor agonists require a 4-week ramp phase?

Clinical trials for GLP-1 medications (like semaglutide and tirzepatide) showed that stepping up dosage every 4 weeks significantly minimizes nausea and GI intolerance compared to rapid dosing escalation.

GLP-1 Ramp Schedule Engine

GLP-1 Dose Titration Calculator

Generate step-up schedule paradigms for Semaglutide, Tirzepatide, and Retatrutide research protocols.

Written by OnePeptideShip Editorial Team

Reviewed by Dr. Aris Thorne, MD, Board Certified Endocrinology Advisor

Updated September 2026

GLP-1 Titration Engine

Dose Escalation Schedule Generator

Select Protocol Preset

Standard 16-week ramp-up protocol based on clinical study paradigms.

Visual Dose Ramp Schedule (Semaglutide)

Weeks 1-4: 0.25 mg (Once weekly)Initial initiation phase

0.25 mg

Weeks 5-8: 0.5 mg (Once weekly)First step-up

0.5 mg

Weeks 9-12: 1 mg (Once weekly)Intermediate dose

1 mg

Weeks 13-16: 1.7 mg (Once weekly)High intermediate

1.7 mg

Weeks 17-20: 2.4 mg (Once weekly)Maximum target research dose

2.4 mg

Timeline	Dose (mg)	Frequency	Protocol Phase
Weeks 1 - 4	0.25 mg	Once weekly	Initial initiation phase
Weeks 5 - 8	0.5 mg	Once weekly	First step-up
Weeks 9 - 12	1 mg	Once weekly	Intermediate dose
Weeks 13 - 16	1.7 mg	Once weekly	High intermediate
Weeks 17 - 20	2.4 mg	Once weekly	Maximum target research dose

Frequently Asked Questions

: Dose titration is the gradual escalation of dosage over specified intervals (typically 4-week steps). This allows the subject's receptors and gastrointestinal system to acclimate, reducing transient side effects.
: Clinical trials for GLP-1 medications (like semaglutide and tirzepatide) showed that stepping up dosage every 4 weeks significantly minimizes nausea and GI intolerance compared to rapid dosing escalation.